Discover Great Companies Discover Great Clients
Popularity  19.3万   |   Followers  293   |   Likes  53   |   Feedback  190 Claim this company

Pursuing excellent quality, creating healthy life

No.141 Tianjin Popularity Ranking No.51 Development Zone No.1 Excipients No.4 Chemistry Pharmaceuticals No.5 Medical Products No.5 APIs No.5 Sheng Wu Ke Ji / Biotechnology Engineering No.5 Healthcare Supplies No.5 Zhong Pharmaceuticals No.5 Gong Cheng Yan Jiu Center No.7 Health No.7 Lin Chuang Yi Xue No.9 Shang Products Supply Chain No.11 Yao Products R&D 企业技术中心 院士工作站 博士后工作站 理事单位 常务理事单位 高新技术企业
More

Company Overview

  • Nature: Listed Company Size: 5000-9999 employees Founded: 26年
  • Industry: Pharmaceutical/Bioengineering 、 Petroleum/Chemical/Mining/Geology
  • Full name: Tianjin Hongri Pharmaceutical Co., Ltd.。

Development Stage

  • Stage: IPO上市, 创业板, 深交所。
  • Ranking: Ranked #141 in Tianjin by popularity Ranked #1 in Tianjin Excipients Company by popularity Ranked #4 in Tianjin Chemistry Pharmaceuticals Company by popularity Ranked #5 in Tianjin Medical Products Company by popularity Ranked #5 in Tianjin APIs Company by popularity
  • Honors: 2023中国企业慈善公益500强 2023中国高新技术企业慈善公益500强 企业技术中心 院士工作站 According to algorithm
  • News: 2026-07-08:红日药业:终止抗丙肝一类化药新药研发项目。
  • Salary: 37% of positions earn 10-20K, In 2026 vs last yeargrew by 34%.。Master's salary: ¥24.9K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 30.4%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 21.7%, "Other (R&D and Technical)": 15.2%。
  • Recruiting: In 2026 vs 2025decreased by 70%. Demand for highly educated talent: Master's: 8.
  • Requirement: Education: 本科 leads with 51.7%. Experience: 不限 leads with 36.2%.
  • Region: Distributed across 3 regions, 天津: 37.9%, 湖州: 19%, 黄冈: 13.8%, 武汉: 10.3%.

About the Company

[Summary] Pursuing excellent quality, creating healthy life

Company Profile
Tianjin Hongri Pharmaceutical Co., Ltd. was established in 1996 and is one of the first batch of listed companies on the ChiNext board of the national stock market. After more than two decades of dedicated efforts, the company has become a high-tech pharmaceutical health industry cluster that spans multiple fields such as finished drugs, traditional Chinese medicine formula granules, raw and auxiliary materials, medical devices, medical health services, and smart supply chain for drugs and devices, integrating investment and financing, production, research and development, and sales. In recent years, the company has consistently ranked among the top 100 pharmaceutical enterprises in China. In 2020, its main business revenue reached 6.488 billion yuan, total assets were 10.18 billion yuan, and tax payments amounted to 540 million yuan. Hongri Pharmaceutical always stands at the forefront of technology, with technological innovation and industrialization of achievements as the source of continuous development. Relying on the two technology platforms established - the National Enterprise Technology Center and the National and Local Joint Engineering Research Center for Key Technologies of Traditional Chinese Medicine Formula Granules - and collaborating with renowned academicians such as Zhong Nanshan and Zhang Boli, the company continuously conducts innovative research on antitumor drugs, the treatment of COVID-19 with Xuebijing, and key technologies for the secondary development of Chinese patent medicines. Hongri Pharmaceutical has always regarded talent cultivation and development as the foundation of the enterprise. We have established an open and efficient communication platform. With a flat organizational structure, clear career advancement paths, performance management mechanisms, and talent incentive systems, we enable Hongri employees to create value and realize their ideals on this platform. Hongri Pharmaceutical has a comprehensive training system that provides sufficient human resources support for enterprise development; we cultivate elite, practical, and high-quality talents, adhering to the talent philosophy of "Competition over selection, achievement determines position." "Inherit and develop Chinese medicine, solve human health problems." Hongri Pharmaceutical will continue to practice the two value propositions of "Striving for the public to enjoy high-quality traditional Chinese medicine services!" and "Striving for the improvement of China's medical treatment level!" and strive to go global and reach the world!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Hongri Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

Hongri Pharmaceutical How Fast Is Hiring Growing? (32 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 34%
  • 2024: Down 16%
  • 2023: Down 33%
  • 2022: Down 59%
Hongri Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Hongri Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Master's 8
Note: How fast is hiring at Tianjin Hongri Pharmaceutical Co., Ltd. growing? Hongri Pharmaceutical2026: 46 openings (down 70%), 2025: 151 openings (down 34%), 2024: 229 openings (down 16%), 2023: 274 openings (down 33%), 2022: 406 openings (down 59%), 2021: 1002 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Hongri Pharmaceutical Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 86%
  • 2023: Up 69%
  • 2022: Up 86%
Hongri Pharmaceutical Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
No.66
Master's Demand Ranking in Tianjin 򀀩
¥8-30K
Master's Salary 򀀩
How fast is master's hiring at Tianjin Hongri Pharmaceutical Co., Ltd. growing? Hongri PharmaceuticalMaster's recruitment over the years: 2025: 3 openings (flat), 2024: 3 openings (down 86%), 2023: 22 openings (up 69%), 2022: 13 openings (up 86%), 2021: 7 openings. Hongri Pharmaceutical master talent ranking in Tianjin: #66, Hongri Pharmaceutical master salary mostly around 8-30K.

Hongri Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Hongri Pharmaceutical Doctoral Hiring by Year: 2024 — 10 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Tianjin Hongri Pharmaceutical Co., Ltd. growing? Hongri PharmaceuticalDoctorate recruitment over the years: 2024: 1 openings (down 86%), 2023: 11 openings (up 69%), 2022: 4 openings (up 86%).

Hongri Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Tianjin Hongri Pharmaceutical Co., Ltd.? Based on an analysis of Hongri Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 30.4%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 21.7%, "Other (R&D and Technical)": 15.2%, "Computer/Network/Technology": 4.3%. For reference only.

Hongri Pharmaceutical — What Are the Salaries Like? (46 records)

Manage
Hongri Pharmaceutical Salary Overview
salary range: 2K - 30K, 37% of roles pay ¥10-20K
Note: salary statistics are based on 46 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Tianjin Hongri Pharmaceutical Co., Ltd.?Hongri Pharmaceutical37% of positions earn 10-20K, Fresh graduate salary: ¥。Tianjin salary ranking top 25,财务/审计/统计类 average salary ¥12.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Hongri Pharmaceutical

(More)
Are salaries high at Tianjin Hongri Pharmaceutical Co., Ltd.? We provide: Technology Management, 药学, Project Implementation, Finance Specialist, 合规, Quality, Auditor, Legal Counsel, Sales, Accountant, Internal Control, Analyst, Security Officer, Intern, 药物警戒, Procurement, pd, QA, 产业研究, Warehouse Staff. Click to view detailed salary analysis by job.

Hongri Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国企业慈善公益500强:

  • NO.220 2023中国企业慈善公益500强 >
  • NO.203 2021中国企业慈善公益500强 >
  • NO.168 2020中国企业慈善公益500强 >

Yes, ranked in 中国高新技术企业慈善公益500强:

  • NO.33 2023中国高新技术企业慈善公益500强 >

Job Category

  • 财务/审计/统计类
    36.2% of total 36.2%
  • 医疗卫生/美容保健类
    27.6% of total 27.6%
  • 质量管理类
    22.4% of total 22.4%
  • 其他(研发和技术类)
    17.2% of total 17.2%

Education

  • 本科
    51.7% of total 51.7%
  • 大专
    25.9% of total 25.9%
  • 硕士
    15.5% of total 15.5%
  • 不限
    6.9% of total 6.9%

Experience

  • 不限
    36.2% of total 36.2%
  • 1-3年
    22.4% of total 22.4%
  • 5-10年
    20.7% of total 20.7%
  • 3-5年
    17.2% of total 17.2%
View Detailed Analysis

What does Tianjin Hongri Pharmaceutical Co., Ltd. require? Who is Hongri Pharmaceutical hiring? Hongri Pharmaceutical recruitment: 财务/审计/统计类占比最多占36.2%,其次是医疗卫生/美容保健类占27.6%. What education can get in at Hongri Pharmaceutical? 本科占比最多占51.7%,其次是大专占25.9%. High education required at Hongri Pharmaceutical? 硕士占15.5%. Work experience required at Hongri Pharmaceutical? 不限占比最多占36.2%,其次是1-3年占22.4%. Where are the job locations at Hongri Pharmaceutical? 天津占比最多占37.9%,其次是湖州占19%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 300,415.4837万(元)
Legal Representative: 吴文元
Date Established:
Credit Code: 9112000010409702XT
Registered Address: 天津新技术产业园区武清开发区泉发路西(存在多址信息)

Partners & Suppliers

上药控股作为华东地区重要经销商,2021年与红日药业签署战略合作,加强院外市场覆盖。 Source
合作客户 药品线下经销
2020年红日药业旗下上医仁家与顺丰同城达成合作,由顺丰同城为中药代煎业务提供同城配送服务。 Source
供应商 同城物流配送
2020年红日药业与中国银行天津市分行签署战略合作协议,获得综合授信、现金管理等金融支持。 Source
供应商 金融服务
2020年红日药业与华为云签署合作协议,华为云为其提供智慧医疗云基础设施。 Source
供应商 云服务
红日药业旗下上医仁家与腾讯健康合作,由腾讯提供平台技术支持,开展线上中医问诊。 Source
供应商 互联网医疗平台

People who follow Hongri Pharmaceutical also follow

Hongri Pharmaceutical Competitors (Similar Companies)

“Technological innovation and commercial application of pharmaceutical ”
“Core corporate philosophy: Harmony between man and nature, benefiting ”
医药 制药/药业 药物研发 原料药
“慢病管理的有力践行者”
“做好人,做好药”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“A landmark enterprise in the modernization of traditional Chinese medi”
“甾体皮质激素类药物科研、生产、出口基地”
心理健康 中医诊疗 中西医结合 诊所/门诊部
医药 药物研发 抗感染药物 化学制药
医疗器械 医药工业 大健康 研发
药品零售 生产 医药科技 加盟
胶粘剂 化工科技 原材料 原料
生物制品 抗生素 中成药 原料药
废气治理 滤膜 海水淡化 中水回用

Discover Great Companies, Discover Great Clients

天津公司名录 天津“Development Zone”公司名录 天津“原料药”公司名录 天津“生物科技/生物工程”公司名录 天津“药物研发”公司名录 天津“化学制药”公司名录 天津“医药工业”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates